Society of Surgical Oncology

Rosemont (United States us)
Oncology

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

1,834
Activity
3%

Total documents

2.32
Impact
3%

Normalized Impact

377
Excellence
3%

Highly Cited Papers (Top 10%)

65.9
Leadership
3%

Leadership (%)

30.1
Mobility & Collaboration
3%

International Collaboration (%)

57
Excellence
3%

Outstanding papers (Top 1%)

9.8
Leadership
3%

Women Leading (%)

4.4
Leadership
3%

Women Leading International (%)

30.3
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Mulshine, James male Pulmonary and Respiratory Medicine Leading researcher 840 44 335 1.90 63 55.5% 13.1%
2 David G. Poplack Public Health, Environmental and Occupational Health Leading researcher 831 51 319 2.49 61 52.4% 9.4%
3 Supervisor, Copy male Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine Junior researcher 803 3 15 0.68 0 0.0% 0.0%
4 Copy, Yasmeen female Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine Junior researcher 803 3 15 0.68 0 0.0% 0.0%
5 Production, Robert male Pulmonary and Respiratory Medicine Junior researcher 801 3 23 0.56 0 0.0% 0.0%
6 Jonathan Graphic Designer Pulmonary and Respiratory Medicine Junior researcher 799 3 21 0.59 0 0.0% 0.0%
7 Hayley Senior Editor Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine Junior researcher 785 3 14 0.59 0 0.0% 0.0%
8 Chris Hennessy Vice Pulmonary and Respiratory Medicine Junior researcher 756 3 15 0.55 0 0.0% 0.0%
9 Pelosci, Ariana female Pulmonary and Respiratory Medicine, Oncology Junior researcher 752 3 29 0.61 0 0.0% 10.3%
10 Mcgarr, Rachel female Pulmonary and Respiratory Medicine Junior researcher 738 3 12 0.64 0 0.0% 0.0%
11 Sr, Mike male Oncology, Pulmonary and Respiratory Medicine, Surgery Junior researcher 737 4 29 0.46 0 51.7% 10.3%
12 Carson, Georgina female Economics and Econometrics, Oncology, Pulmonary and Respiratory Medicine Researcher 737 10 55 0.96 7 0.0% 7.3%
13 Angeles, Apar female Oncology, Pathology and Forensic Medicine, Surgery Junior researcher 722 3 23 0.46 0 0.0% 13.0%
14 Salani, Los male Oncology, Pulmonary and Respiratory Medicine Junior researcher 711 3 22 0.57 0 0.0% 9.1%
15 Janjan, Danielle female Oncology Junior researcher 710 3 19 0.65 0 0.0% 15.8%
16 Copy, Senior female Pulmonary and Respiratory Medicine Junior researcher 708 3 13 0.48 0 0.0% 0.0%
17 Bao, New male Oncology, Pulmonary and Respiratory Medicine Junior researcher 706 3 20 0.54 0 0.0% 10.0%
18 Daver, Ehab male Pulmonary and Respiratory Medicine, Oncology Junior researcher 704 3 20 0.51 0 0.0% 15.0%
19 Glodé, Paul male Oncology, Pulmonary and Respiratory Medicine Junior researcher 699 3 24 0.52 0 0.0% 8.3%
20 Lundenberg, Shari female Oncology Junior researcher 692 4 19 0.74 0 0.0% 5.3%
21 Psycho-Oncology, N Oncology, Pulmonary and Respiratory Medicine Researcher 688 6 28 0.55 0 0.0% 17.9%
22 Panarotti, Ron male Surgery Junior researcher 678 4 15 1.06 1 0.0% 0.0%
23 Melanoma, G Oncology Junior researcher 661 5 28 0.43 0 0.0% 17.9%
24 Beeler, Dori female Oncology Researcher 657 48 122 1.56 11 53.3% 23.0%
25 Ne, Daniel male Oncology, Pulmonary and Respiratory Medicine Junior researcher 653 5 29 0.36 0 0.0% 13.8%
840
One Index
Mulshine, James PhD   0000-0002-4648-9177 335 docs (1981 - 2024)  
Lung Cancer , CT Screening , Cancer Imaging , Tumor Staging , Non-Small Cell Lung Cancer
831
One Index
David G. Poplack PhD 319 docs (1974 - 2024)  
Treatment Outcomes , Acute lymphocytic leukemia , Mercaptopurine , Childhood Cancer Survivor Study , Acute Lymphoblastic Leukemia
803
One Index
Supervisor, Copy 15 docs (2022 - 2022)  
Brentuximab vedotin , Neoadjuvant Therapy , Metastatic Bladder Cancer , Bladder Cancer , Mantle Cell Lymphoma
803
One Index
Copy, Yasmeen 15 docs (2022 - 2022)  
Brentuximab vedotin , Neoadjuvant Therapy , Metastatic Bladder Cancer , Bladder Cancer , Mantle Cell Lymphoma
801
One Index
Production, Robert 23 docs (2022 - 2024)  
Targeted therapy , Brentuximab vedotin , Neoadjuvant Therapy , Metastatic Bladder Cancer , Bladder Cancer
799
One Index
Jonathan Graphic Designer 21 docs (2022 - 2024)  
Brentuximab vedotin , Neoadjuvant Therapy , Metastatic Bladder Cancer , Bladder Cancer , Mantle Cell Lymphoma
785
One Index
Hayley Senior Editor 14 docs (2022 - 2022)  
Brentuximab vedotin , Mantle Cell Lymphoma , Targeted therapy , Romidepsin , Anaplastic large-cell lymphoma
756
One Index
Chris Hennessy Vice 15 docs (2022 - 2022)  
Brentuximab vedotin , Mantle Cell Lymphoma , Targeted therapy , Romidepsin , Anaplastic large-cell lymphoma
752
One Index
Pelosci, Ariana 29 docs (2022 - 2024)  
Refractory (planetary science) , Mantle Cell Lymphoma , Targeted therapy , Brentuximab vedotin , Neoadjuvant Therapy
738
One Index
Mcgarr, Rachel 12 docs (2022 - 2023)  
Brentuximab vedotin , Romidepsin , Anaplastic large-cell lymphoma , Chemoimmunotherapy , Childhood Cancer Survivor Study
737
One Index
Sr, Mike 29 docs (2021 - 2024)  
Targeted therapy , Trk receptor , Guideline , Hyperlipidemia , Refractory (planetary science)
737
One Index
Carson, Georgina PhD 55 docs (2015 - 2024)  
Specialty , Guideline , Targeted therapy , Spinal Muscular Atrophy , Hyperlipidemia
722
One Index
Angeles, Apar 23 docs (2022 - 2023)  
Mantle Cell Lymphoma , T Cell Therapy , Brentuximab vedotin , Chemoimmunotherapy , Neoadjuvant Therapy
711
One Index
Salani, Los 22 docs (2022 - 2023)  
Mantle Cell Lymphoma , Brentuximab vedotin , Neoadjuvant Therapy , Metastatic Bladder Cancer , Refractory (planetary science)
710
One Index
Janjan, Danielle 19 docs (2022 - 2023)  
Neoadjuvant Therapy , Mantle Cell Lymphoma , Metastatic Bladder Cancer , Bladder Cancer , T Cell Therapy
708
One Index
Copy, Senior 13 docs (2022 - 2024)  
Brentuximab vedotin , Mantle Cell Lymphoma , Venetoclax , Targeted therapy , Romidepsin
706
One Index
Bao, New 20 docs (2022 - 2023)  
Mantle Cell Lymphoma , T Cell Therapy , Brentuximab vedotin , Chemoimmunotherapy , Neoadjuvant Therapy
704
One Index
Daver, Ehab 20 docs (2022 - 2023)  
Refractory (planetary science) , Mantle Cell Lymphoma , Brentuximab vedotin , Salvage therapy , Romidepsin
699
One Index
Glodé, Paul 24 docs (2022 - 2024)  
Mantle Cell Lymphoma , Brentuximab vedotin , Neoadjuvant Therapy , Metastatic Bladder Cancer , Refractory (planetary science)
692
One Index
Lundenberg, Shari 19 docs (2021 - 2023)  
Trk receptor , Neoadjuvant Therapy , T-Cell Lymphoma , Bladder Cancer , T Cell Therapy
688
One Index
Psycho-Oncology, N PhD 28 docs (2019 - 2023)  
Mantle Cell Lymphoma , Refractory (planetary science) , T Cell Therapy , Brentuximab vedotin , Chemoimmunotherapy
678
One Index
Panarotti, Ron 15 docs (2021 - 2022)  
Guideline , Hyperlipidemia , Spinal Muscular Atrophy , PCSK9 , Cholesterol-lowering
661
One Index
Melanoma, G 28 docs (2020 - 2023)  
Mantle Cell Lymphoma , Targeted therapy , Refractory (planetary science) , T Cell Therapy , Chemoimmunotherapy
657
One Index
Beeler, Dori PhD   0000-0002-2904-2752 122 docs (1977 - 2024)  
Depression (economics) , Childhood Cancer Survivor Study , Depression , Adolescent and Young Adult Oncology , Cancer Survivorship
653
One Index
Ne, Daniel 29 docs (2020 - 2024)  
Targeted therapy , Mantle Cell Lymphoma , Chemoimmunotherapy , Neoadjuvant Therapy , Clinical Oncology